BackAkebia Therapeutics Overview

Akebia Therapeutics Goodwill

Akebia Therapeutics's goodwill is $59M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$59.04M
0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Akebia Therapeutics Goodwill History

Loading

Akebia Therapeutics vs. peers: Goodwill Comparison

Loading

Akebia Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Akebia Therapeutics (AKBA) FAQ

As of the most recent data (June 2026), AKBA shows a goodwill of $59M. That compares with $59M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AKBA's goodwill is now $59M (was $59M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Akebia Therapeutics is outperforming or lagging.

Tracking AKBA's goodwill over time shows whether Akebia Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $59M That compares with $59M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Akebia Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $59M) with ownership activity and broader fundamentals.

Akebia Therapeutics's goodwill is $59M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.